glp 1 analogue drugs Evolution of GLP‐1 Receptor Agonists for Diabetes Treatment List of current GLP-1 and

Press Release June 18 2020

IR, insulin resistance

The novel use of GLP-1 analogue and insulin combination in type 2 diabetes mellitus

Tang Y, Arbaugh B, Park H, Scher HB, Bai L, Mao L, et al

It may involve amylin biology, oral delivery, muscle-preserving weight loss, MASH differentiation, or long-acting dosing platforms

The distinct expression patterns suggest nuanced and potentially non-redundant roles for GLP-1 signaling in these systems.27 Activation of GLP-1 neurons in the NTS has been shown to reduce metabolic rates and suppress food intake in both fed and fasted murine models.2,28,34 Moreover, stimulation of NTS GLP-1 neurons inhibits hepatic glucose production without altering peripheral glucose uptake, illustrating the involvement of the central GLP-1 system in energy homeostasis and glucose metabolism.34,35 The hypothalamus serves as a principal downstream target for peripherally administered GLP-1RAs and GLP-1 neurons originating in the hindbrain.36 Pharmacological studies in whole-animal models have demonstrated that the activation of GLP-1 receptors enhances glucose tolerance and suppresses food intake, thereby facilitating weight loss and improving glucose homeostasis.37,38 Genetic approaches in mice further corroborate the physiological significance of GLP-1 receptor in the regulation of energy balance and glucose metabolism